EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Uremic Toxins, CKD, and Cognitive Dysfunction

Taylor D Andrews iD, Gregory S Day iD, Sarosh R Irani iD, Takahisa Kanekiyo iD, LaTonya J Hickson

Journal of the American Society of Nephrology · 2025-06 · 36 (6) · 1208-1226

DOI: 10.1681/asn.0000000675 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of the American Society of Nephrology, online erschienen am 26.02.2025. Verfasst von Taylor D Andrews und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosciences, Mayo Clinic Graduate School Biomedical Sciences, Mayo Clinic, Jacksonville, Florida. Hauptthemen laut MEDLINE: Cognitive Dysfunction, Renal Insufficiency, Chronic, Uremic Toxins. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NIH HHS, Wellcome Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cognitive impairment involves alterations to one's cognitive status that affects everyday life. Individuals with CKD, and particularly kidney failure, experience higher rates of cognitive impairment (20%–70%) compared with the general population. The highest prevalence is described in kidney failure such that dialysis-dependent patients have twice the prevalence of age-matched controls. In the past 5 years, the number of investigations examining the “kidney-brain axis,” mechanisms of CKD-related cognitive impairment, and potential therapeutics have exponentially increased. This review article summarizes recent literature on direct and indirect effects of CKD-associated cognitive impairment with emphasis on uremic toxins; brain injury mechanisms; overlap between CKD-associated cognitive impairment, Alzheimer's disease, and other neurodegenerative diseases. Reviewed therapeutic interventions include AST-120 (indoxyl sulfate absorbent), CH-223191 (aryl hydrocarbon receptor antagonist), triarylmethane-34 (Kca3.1-specific inhibitor), anakinra (IL-1R inhibitor), marimastat, exercise, supplements, and kidney transplantation. Special focus is placed on translational studies examining uremic toxin–associated pathogenic processes, including brain oxidative stress, neuroinflammation, and blood-brain barrier dysfunction through in vitro and in vivo models of CKD-associated brain injury. Finally, future research directions are suggested, including targeting of cellular senescence abundance with senotherapeutics and capitalizing on anti-inflammatory effects of regenerative, cell-based therapeutics ( e.g ., mesenchymal stem cells and extracellular vesicles), and use of aged murine models. Collectively, CKD-associated cognitive impairment represents a prevalent condition for which remaining knowledge gaps exist, and scientific advancements are needed to preserve cognitive function and improve the lives of individuals with CKD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cognitive DysfunctionRenal Insufficiency, ChronicUremic ToxinsHumansAnimalsOxidative StressUremia

Stichwörter der Autor:innen

ApoECKD nondialysisESKDbiomarkersdementiadialysisimagingtransplantationuremia

Substanzen

Uremic Toxins

Autor:innen und Institutionen

  • Department of Neurosciences, Mayo Clinic Graduate School Biomedical Sciences, Mayo Clinic, Jacksonville, Florida.
  • Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Jacksonville, Florida.
  • Department of Neurology, Mayo Clinic, Jacksonville, Florida.
  • Department of Neurosciences, Mayo Clinic, Jacksonville, Florida.

ORCID-Profile: Taylor D Andrews, Gregory S Day, Sarosh R Irani, Takahisa Kanekiyo

Förderung

  • NIA NIH HHS
  • NIH HHS
  • Wellcome Trust
  • NINDS NIH HHS
  • Medical Research Council
  • Wellcome Trust Fellowship
  • National Institute on Aging
  • National Institutes of Health

Zitieren

APA

Andrews, T. D., Day, G. S., Irani, S. R., Kanekiyo, T., & Hickson, L. J. (2025). Uremic Toxins, CKD, and Cognitive Dysfunction. Journal of the American Society of Nephrology, 36(6), 1208-1226. https://doi.org/10.1681/asn.0000000675

Vancouver

Andrews TD, Day GS, Irani SR, Kanekiyo T, Hickson LJ. Uremic Toxins, CKD, and Cognitive Dysfunction. Journal of the American Society of Nephrology. 2025;36(6):1208-1226. doi:10.1681/asn.0000000675

BibTeX
@article{Andrews2025,
  author = {Andrews, Taylor D and Day, Gregory S and Irani, Sarosh R and Kanekiyo, Takahisa and Hickson, LaTonya J},
  title = {Uremic Toxins, CKD, and Cognitive Dysfunction},
  journal = {Journal of the American Society of Nephrology},
  year = {2025},
  volume = {36},
  number = {6},
  pages = {1208--1226},
  doi = {10.1681/asn.0000000675}
}
Kostenlos starten →